Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shruti Therapeutics was a biotechnology company focused on developing novel therapies for skin diseases by leveraging the skin microbiome. Founded as an internal entity within PureTech Health, the company aimed to identify and harness specific microbial strains and their metabolites to treat inflammatory and infectious skin conditions. Its research centered on the interaction between the skin's immune system and its resident microorganisms to restore healthy skin function. Although the company was active in the mid-2010s, its programs were eventually integrated into other PureTech initiatives or discontinued as the parent company shifted its portfolio focus.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shruti K.